ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

ASN / Education & Meetings / Kidney Week /

Please note that you are viewing an archived section from 2021 and some content may be unavailable. To unlock all content for 2021, please visit the archives.

Abstract: PO0570

Low Magnesium Is Associated with Weak Bone Strength in Pre-Dialysis CKD Patients: Results from the KNOW-CKD Study

Session Information

Category: Bone and Mineral Metabolism

  • 402 Bone and Mineral Metabolism: Clinical

Authors

  • Kang, Minjung, Seoul National University College of Medicine, Seoul, Korea (the Republic of)
  • Kang, Eunjeong, Ewha Womans University, Seoul, Korea (the Republic of)
  • Ahn, Curie, Seoul National University College of Medicine, Seoul, Korea (the Republic of)
  • Oh, Kook-Hwan, Seoul National University College of Medicine, Seoul, Korea (the Republic of)
Background

In patients with chronic kidney disease (CKD), bone strength was weakened as CKD progressed. There are still controversy of the association between magnesium (Mg) deficiency and osteoporosis in pre-dialysis CKD patients.

Methods

We investigated the association between serum Mg and a decrease of bone mineral density (BMD) from the prospective, multicenter cohort of pre-dialysis CKD patients (n=928). Patients were divided into tertiles according to serum Mg. The primary endpoint is a decrease of BMD, defined as decline of BMD of lumbar spine <-0.05g/cm2. We performed sensitivity analysis with decline of BMD of femur neck.

Results

After 4 years of follow-up, BMD decreased in 267 (28.7%) patients. In a multivariable binary logistic regression model, the lowest tertile of Mg was associated with risk of the decrease of BMD of lumbar spine (T1, serum Mg ≤2.2 mg/dL, Odd ratio (OR) 2.79 [1.58−4.92]; P=<0.001; T3, serum Mg ≥2.3 mg/dL, reference group). Similar results were obtained when sensitivity analysis was performed with BMD of femur neck. Subgroup analyses showed that low Mg was particularly associated with risk of the decreased BMD of lumbar spine in patients <50 years of age, in those without diabetes mellitus, and in those with low physical activity.

Conclusion

Low level of Mg is associated with a weak bone strength in pre-dialysis CKD patients.